This provider's $6.3M in total Medicare payments ranks in the 95th percentile of Ambulatory Surgical Center providers nationally.
Their average markup ratio of 5.75x is significantly above the specialty median of 6.1x.
Medicare payments to this provider grew 123% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $2.2K | $453.56 | 4.81x | $1.7K | $398.6K | 1.5K | 1.3K |
| 2015 | $2.2K | $481.50 | 4.53x | $1.7K | $469.6K | 1.6K | 1.4K |
| 2016 | $2.2K | $449.53 | 4.85x | $1.7K | $485.1K | 1.6K | 1.5K |
| 2017 | $2.2K | $458.74 | 4.70x | $1.7K | $520.9K | 1.7K | 1.6K |
| 2018 | $2.2K | $403.53 | 5.48x | $1.8K | $556.7K | 1.9K | 1.7K |
| 2019 | $2.2K | $405.75 | 5.45x | $1.8K | $563.4K | 2.0K | 1.8K |
| 2020 | $2.9K | $1.1K | 2.73x | $1.9K | $768.0K | 2.0K | 1.8K |
| 2021 | $2.9K | $1.1K | 2.59x | $1.8K | $858.5K | 2.2K | 2.0K |
| 2022 | $3.1K | $1.1K | 2.71x | $1.9K | $824.7K | 2.4K | 2.1K |
| 2023 | $3.4K | $1.2K | 2.74x | $2.1K | $890.3K | 2.5K | 2.2K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 9.4K | $1.8M | $196.82 | 10.07x |
| 55700 | Biopsy of prostate gland | 2.7K | $1.5M | $555.79 | 3.95x |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | 2.5K | $1.4M | $552.81 | 4.21x |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 87 | $436.9K | $5.0K | 1.88x |
| 52287 | Examination with injections of chemical for destruction of bladder using an endoscope | 573 | $326.5K | $569.78 | 4.12x |
| 64561 | Insertion of sacral nerve neurostimulator electrodes, accessed through the skin | 84 | $285.5K | $3.4K | 2.01x |
| 52224 | Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope | 196 | $146.3K | $746.27 | 3.29x |
| 52315 | Complicated removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | 235 | $141.0K | $600.14 | 6.00x |
| 76872 | Ultrasound of rectum | 2.7K | $107.6K | $39.57 | 10.74x |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | 190 | $102.7K | $540.52 | 4.41x |
| C9748 | Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy | 54 | $28.4K | $525.33 | 8.57x |
| 53852 | Destruction of prostate tissue through bladder canal (urethra) | 22 | $23.7K | $1.1K | 3.87x |
| 53854 | Destruction of prostate tissue accessed through urethra using radiofrequency generated water vapor heat therapy | 14 | $7.3K | $523.80 | 8.59x |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 573 | $2.8K | $4.88 | 3.33x |
This provider submits charges 5.75 times higher than what Medicare actually pays.
A markup ratio of 5.75x means for every $100 Medicare pays, this provider initially charges $575. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data